Immunization with purified natural and recombinant allergens induces mouse IgG1 antibodies that recognize similar epitopes as human IgE and inhibit the human IgE-allergen interaction and allergen-induced basophil degranulation

Journal of Immunology

Volumn 160, Issue 12, 1998, Pages 6137-6144

  Vrtala, Susanne ^a   Ball, Tanja ^a   Spitzauer, Susanne ^a   Pandjaitan, Budhi ^a   Suphioglu, Cenk ^b   Knox, Bruce ^b   Sperr, Wolfgang R ^a   Valent, Peter ^a   Kraft, Dietrich ^a   Valenta, Rudolf ^a,c  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; RECOMBINANT PROTEIN;

ALLERGY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; DANDER; GRASS POLLEN; IMMUNIZATION; IMMUNOGENICITY; IMMUNOMODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ALLERGENS; ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; BASOPHIL DEGRANULATION TEST; BASOPHILS; DESENSITIZATION, IMMUNOLOGIC; DOGS; EPITOPE MAPPING; HISTAMINE RELEASE; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; KINETICS; MICE; RECOMBINANT PROTEINS;

EID: 15444353066     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Kaplan, A. P. 1985. Allergy. Churchill Livingstone, New York.
2. Cooke, R., J. Barnard, S. Hebald, and A. Stull. 1935. Serological evidence on immunity with co-existing sensitization in a type of human allergy, hay fever, J. Exp. Med. 62:733.
3. Loveless, M. H. 1940. Immunological studies of pollinosis. I. The presence of two antibodies related to the same pollen-antigen in the serum of treated hay fever patients. J. Immunol. 38:1925.
4. Loveless, M. H. 1943. Immunological studies on pollinosis. IV. The relationship between thermostable antibody in the circulation and clinical immunity. J. Immunol. 47:165.
5. Scully, M., and F. Rackemann. 1941. Studies on the blocking antibody of Cooke in treatment of hayfever. J. Allergy 12:549.
6. Lichtenstein, L. M., N. A. Holtzman, and L. S. Burnett. 1968. A quantitative in vitro study of the Chromatographic distribution and immunoglobulin characteristics of human blocking antibody. J. Immunol. 101:317.
7. Sobotka, A. K., M. D. Valentine, K. Ishizaka, and L. M. Lichtenstein. 1976. Measurement of IgG blocking antibodies: development and application of a radioimmunoassay. J. Immunol. 117:84.
8. Adkinson, N. F., A. K. Sobotka, and L. M. Lichtenstein. 1979. Evaluation of the quantity and affinity of human IgG "blocking" antibodies. J. Immunol. 122:965.
9. Gleich, G. J., E. M. Zimmermann, M. C. Gleich, and J. W. Yunginger. 1981. Measurement of IgG blocking antibodies by interference in the radioallergosorbent test. J. Immunol. 126:575.
10. 4-restricted response. J. Immunol. 130:722.
11. Birkner, T., H. Rumpold, E. Jarolim, H. Ebner, M. Breitenbach, T. Skvaril, O. Scheiner, and D. Kraft. 1990. Evaluation of immunotherapy-induced changes in specific IgE. IgG and IgG subclasses in birch pollen allergic patients by means of immunoblotting: correlation with clinical response. Allergy 45:418.
12. Visco, V., C. Dolecek, S. Denepoux, J. Le Mao, C. Guret, F. Rousset, M. T. Guinnepain, D. Kraft, R. Valenta, A. Weyer, J. Banchereau, and S. Lebecque. 1996. Human monoclonal antibodies that modulate the binding of specific IgE to birch pollen Bet v 1. J. Immunol. 157:956.
13. Lebecque, S., C. Dolecek, S. Laffer, V. Visco, S. Denepoux, J. J. Pin, C. Guret, G. Boltz-Nitulescu, A. Weyer, and R. Valenta. 1997. Immunologic characterization of monoclonal antibodies that modulate human IgE binding to the major birch pollen allergen Bet v 1. J. Allergy Clin. Immunol. 99:374.
14. Laffer, S., R. Valenta, S. Vrtala, M. Susani, R. vanRee, D. Kraft, O. Scheiner, and M. Duchêne. 1994. cDNA cloning of the major allergen Ph1 p l from timothy grass (Phleum pratense): recombinant Ph1 p 1 inhibits IgE-binding to group I allergens from eight different grass species. J. Allergy Clin. Immunol. 94:689.
15. Dolecek, C., S. Vrtala, S. Laffer, P. Steinberger, D. Kraft, O. Scheiner, and R. Valenta. 1993. Molecular characterization of Ph1 p 2. a major timothy grass (Phleum pratense) pollen allergen. FEBS Lett. 335:299.
16. Vrtala, S., W. R. Sperr, I. Reimitzer, R. vanRee, S. Laffer, W. D. Müller, P. Valent, K. Lechner, H. Rumpold, D. Kraft, O. Scheiner, and R. Valenta. 1993. cDNA cloning of a major allergen from timothy grass (Phleum pratense) pollen: characterization of the recombinant Ph1 p 5 allergen. J. Immunol. 151:4773.
17. Spitzauer, S., C. Schweiger, W. R. Sperr, B. Pandjaitan, P. Valent, S. Mühl, C. Ebner, O. Scheiner, D. Kraft, H. Rumpold, and R. Valenta. 1994. Molecular characterization of dog albumin as a cross-reactive allergen. J. Allergy Clin. Immunol. 93:614.
18. Spitzauer, S., B. Pandjaitan, G. Söregi, S. Mühl, C. Ebner, D. Kraft, R. Valenta, and H. Rumpold. 1995. IgE-crossreactivities against albumins in patients allergic to animals. J. Allergy Clin. Immunol. 96:951.
19. Valenta, R., M. Duchêne, S. Vrtala, T. Birkner, C. Ebner, R. Hirschwehr, M. Breitenbach, H. Rumpold, O. Scheiner, and D. Kraft. 1991. Recombinant allergens for immunoblot diagnosis of tree-pollen allergy. J. Allergy Clin. Immunol. 88:889.
20. Valenta, R., S. Vrtala, C. Ebner, D. Kraft, and O. Scheiner. 1992. Diagnosis of grass pollen allergy with recombinant timothy grass (Phleum pratense) pollen allergens. Int. Arch. Allergy Immunol 97:287.
21. Vrtala, S., M. Grote, M. Duchêne, R. vanRee, D. Kraft, O. Scheiner, and R. Valenta. 1993. Properties of tree and grass pollen allergens: reinvestigation of the linkage between solubility and allergenicity. Int. Arch. Allergy Immunol. 102:160.
22. Fling, S. P., and D. S. Gregerson. 1986. Peptide and protein molecular weight determination by electrophoresis using a high molarity Tris buffer system without urea. Anal. Biochem. 155:83.
23. Bradford, M. M. 1976. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye-binding. Anal. Biochem. 72:248.
24. Vrtala, S., M. Susani, W. R. Sperr, P. Valent, S. Laffer, C. Dolecek, D. Kraft, and R. Valenta. 1996. Immunologic characterization of purified recombinant timothy grass pollen (Phleum pratense) allergens (Ph1 p 1, Ph1 p 2, Ph1 p 5). J. Allergy Clin. Immunol. 97:781.
25. Way, M., B. Pope, J. Gooch, M. Hawkins, and A. G. Weeds. 1990. Identification of a region in segment 1 of gelsolin critical for actin binding. EMBO J. 9:4103.
26. + gene, expressed under the control of the mating-type locus, induces meiosis and sporulation in fission yeast. EMBO J. 6:729.
27. Studier, F. W., A. H. Rosenberg, J. J. Dunn, and J. W. Dubendorff. 1990. Use of the T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol. 185:60.
28. Vrtala, S., M. Grote, F. Ferreira, M. Susani, B. Stocker, D. Kraft, and R. Valenta. 1995. Humoral immune responses to recombinant tree pollen allergens (Bet v 1, Bet v 2) in mice: construction of a live oral allergy vaccine. Int. Arch. Allergy Immunol. 107:290.
29. Vrtala, S., P. Mayer, F. Ferreira, M. Susani, A. H. Schon, D. Kraft, and R. Valenta. 1996. Induction of IgE antibodies in mice and rhesus monkeys with recombinant birch pollen allergens: different allergenicity of Bet v 1 and Bet v 2. J. Allergy Clin. Immunol. 98:913.
30. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfers of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76:4350.
31. Ball, T., S. Vrtala, W. R. Sperr, P. Valent, M. Susani, D. Kraft, and R. Valenta. 1994. Isolation of an immunodominant IgE hapten from an expression cDNA library. J. Biol. Chem. 269:28323.
32. Ong, E. K., R. B. Knox, and M. B. Singh. 1995. Mapping of the antigenic and allergenic epitopes of Lo1 p VB using gene fragmentation. Mol. Immunol. 32:295.
33. Sambrook, J., E. F. Fritsch, and T. Manlatis, eds. Molecular Cloning: A Laboratory Manual. 1989. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
34. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463.
35. Valent, P., J. Besemer, M. Muhm, O. Majdic, K. Lechner, and P. Bettelheim. 1989. Interleukin 3 activates human blood basophils via high-affinity binding sites. Proc. Natl. Acad. Sci. USA 86:5542.
36. Valenta, R., and T. Ball. 1997. Antibody recognition of recombinant allergens and allergen fragments: evidence for a predominantly direct class switch to IgE in allergic patients. In IgE Regulation: Molecular Mechanisms. D. Vercelli, ed. John Wiley & Sons Ltd., Chichester, U.K., p. 225.
37. Ferreira, F., P. Mayer, W. R. Sperr, P. Valent, S. Seiberler, C. Ebner, E. Liehl, O. Scheiner, D. Kraft, and R. Valenta. 1996. Induction of IgE antibodies with predefined specificity in rhesus monkeys with recombinant birch pollen allergens, Bet v 1 and Bet v 2. J. Allergy Clin. Immunol. 97:95.
38. Breiteneder, H., K. Pettenburger, A. Bito, R. Valenta, D. Kraft, H. Rumpold, O. Scheiner, and M. Breitenbach. 1989. The gene coding for the major birch pollen allergen, Bet v 1, is highly homologous to a pea disease resistance response gene. EMBO J. 8:1935.
39. Menz, G., C. Dolecek, U. Schönheit-Kenn, F. Ferreira, M. Moser, T. Schneider, M. Suter, G. Boltz-Nitulescu, C. Ebner, D. Kraft, and R. Valenta. 1996. Serological and skin-test diagnosis of birch pollen allergy with recombinant Bet v 1, the major birch pollen allergen. Clin. Exp. Allergy 26:50.
40. Pauli, G., J. P. Oster, P. Deviller, S. Heiss, J. C. Bessot, M. Susani, F. Ferreira, D. Kraft, and R. Valenta. 1996. Skin testing with recombinant allergens rBet v 1 and birch profilin, rBet v 2: diagnostic value for birch pollen and associated allergies. J. Allergy Clin. Immunol. 97:1100.
41. Valenta, R., M. Duchêne, K. Pettenburger, C. Sillaber, P. Valent, P. Bettelheim, M. Breitenbach, H. Rumpold, D. Kraft, and O. Scheiner. 1991. Identification of profilin as a novel pollen allergen: IgE autoreactivity in sensitized individuals. Science 253:557.
42. Gajhede, M., P. Osmark, F. M. Poulsen, H. Ipsen, J. N. Larsen, R. J. Jost van Neerven, C. Schou, H. Lowenstein, and M. D. Spangfort. 1996. X-ray and NMR structure of Bet v 1, the origin of birch pollen allergy. Nat. Struct. Biol. 3:1040.
43. Fedorov, A. A., T. Ball, N. M. Mahoney, R. Valenta, and S. C. Almo. 1997. The molecular basis for allergen cross-reactivity: crystal structure and IgE-epitope mapping of birch pollen profilin. Structure 5:33.
44. Gleich, G. J., E. M. Zimmermann, L. L. Henderson, and J. W. Yunginger. 1982. Effect of immunotherapy on immunoglobulin E and immunoglobulin G antibodies to ragweed antigens: a six-year prospective study. J. Allergy Clin. Immunol. 70:261.
45. Urbanek, R., D. M. Kemeny, and D. Richards. 1986. Sub-class of IgG anti-bee venom antibody produced during bee venom immunotherapy and its relationship to long-term protection from bee stings and following termination of venom immunotherapy. Clin. Allergy 16:317.
46. Rocklin, R. E. 1989. Immune mechanisms in allergen-specific immunotherapy. Clin. Immunol. Immunopathol. 53:119.
47. Ohman, J. E. Jr. 1991. Clinical and immunological responses to immunotherapy. In Allergens and Allergen Immunotherapy. R. F. Lockey and S. C. Buckantz, eds. Marcel Dekker, Inc., New York, p. 209.
48. Valenta, R., and D. Kraft. 1995. Recombinant allergens for diagnosis and therapy of allergic diseases. Curr. Opin. Immunol. 7:751.
49. van Ree, R., W. A. van Leeuwen, P. H. Dieges, R. G. van Wijk, N. de long, P. Z. Brewczyski, A. M. Kroon, P. P. Schilte, K. Y. Tan, I. F. Simon- Licht, A. M. Roberts, S. O. Stapel, and R. C. Aalberse. 1997. Measurement of IgE antibodies against purified grass pollen allergens (Lo1 p 1, 2, 3 and 5) during immunotherapy. Clin. Exp. Allergy 27:68.
50. Vrtala, S., K. Hirtenlehner, L. Vangelista, A. Pastore, H. G. Eichler, W. R. Sperr, P. Valent, C. Ebner, D. Kraft, and R. Valenta. 1997. Conversion of the major birch pollen allergen. Bet v 1, into two non-anaphylactic T cell epitope-containing fragments: candidates for a novel form of specific immunotherapy. J. Clin. Invest. 99:1673.
51. Zeiler, T., A. Taivainen, M. Rytkönen, J. Rautiainen, H. Karjalainen, R. Mäntyjärvi, L. Tuomisto, and T. Virtanen. 1997. Recombinant allergen fragments as candidate preparations for allergen immunotherapy. J. Allergy Clin. Immunol. 100:721.
52. Smith, A. M., and M. D. Chapman. 1996. Reduction in IgE binding to allergen variants generated by site-directed mutagenesis: contribution of disulphide bonds to the antigenic structure of the major house dust mite allergen Der p 2. Mol. Immunol 33:399.
53. Ferreira, F., K. Hirtenlehner, A. Jilek, J. Godnik-Cvar, H. Breiteneder, R. Grimm, K. Hoffmann-Sommergruber, O. Scheiner, D. Kraft, M. Breitenbach, H. J. Rheinberger, and C. Ebner. 1996. Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1 : potential use of hypoallergenic isoforms for immunotherapy. J. Exp. Med. 183:599.
54. Takai, T., T. Yokota, M. Yasue, C. Nishiyama, T. Yuuki, A. Mori, H. Okudaira, and Y. Okumura. 1997. Engineering of the major house dust mite allergen Der f 2 for allergen-specific immunotherapy. Nat. Biotechnol. 15:754.